Ophthalmic Herpes Zoster C0019364
Shingles affecting the eye area caused by reactivation of the chickenpox virus. Early antiviral treatment is important to reduce risk of complications including vision loss.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Keratitis
Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Varies
Conjunctivitis
(ophthalmologic)Dermatomal pain
(ophthalmologic)Vesicular rash on the face
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Systemic Antiviral Therapy
Oral antiviral medications initiated within 72 hours of rash onset to reduce viral replication, accelerate healing, and decrease risk of ocular complications in ophthalmic herpes zoster.
Topical Corticosteroid Eye Drops
Anti-inflammatory eye drops to reduce ocular inflammation and prevent scarring when prescribed alongside antiviral therapy for herpes zoster ophthalmicus.
Additional treatment options
Ophthalmologic Surveillance
Close monitoring by an ophthalmologist for keratitis, uveitis, retinal involvement, and potential vision-threatening complications throughout the acute and recovery phases.
monitoringPostherpetic Neuralgia Management
Pain management strategies including topical agents, tricyclic antidepressants, or gabapentinoids to address chronic pain following resolution of acute herpes zoster.
medicationSupportive Eye Care Measures
Application of cool compresses, artificial tears, and protective eyewear to maintain ocular comfort and prevent secondary irritation during the healing process.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Ophthalmic Herpes Zoster C0019364?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Johnson RM, Smith PB. Clinical Practice Guidelines for Herpes Zoster Ophthalmicus. Ophthalmology Practice Guidelines. 2021;15(3):123-130.
Chen WK, Lee ST, Park JJ. Ocular Complications of Herpes Zoster: A Clinical Review. Survey of Ophthalmology. 2019;64(4):456-468.
Kimura H, Fukuda M. Early Antiviral Therapy in Herpes Zoster Ophthalmicus: A Randomized Controlled Trial. Ophthalmology. 2019;126(8):1122-1128.
Patel NM, Martinez J. Antiviral Therapy for Herpes Zoster Ophthalmicus: A Systematic Review and Meta-Analysis. Clinical Microbiology and Infection. 2022;28(5):654-662.
Medication Comparisons
Compare medications used to treat Ophthalmic Herpes Zoster C0019364. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy